Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age ≥ 18 Years Old”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04950816
What this trial is testing

Examining the Feasibility and Acceptability of a Tailored Version of a Mindfulness-Based Intervention (MBI) Among Youth Experiencing Homelessness (YEH)

Who this might be right for
Stress, Emotional
The University of Texas Health Science Center, Houston 90
Post-approval studies (Phase 4)UnknownNCT01360710
What this trial is testing

The Effect of Moxonidine on Blood Pressure and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension

Who this might be right for
Abdominal ObesityHypertension
Baker Heart and Diabetes Institute 100
Not applicableStudy completedNCT01891409
What this trial is testing

Use of the Shang Ring Circumcision Device in Boys Below 18 Years Old in Kenya

Who this might be right for
Human Immunodeficiency Virus
EngenderHealth 80
Large-scale testing (Phase 3)Study completedNCT04510207
What this trial is testing

Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above

Who this might be right for
COVID-19
China National Biotec Group Company Limited 44,101
Large-scale testing (Phase 3)Looking for participantsNCT04782258
What this trial is testing

See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

Who this might be right for
Autosomal Recessive Polycystic Kidney (ARPKD)
Otsuka Pharmaceutical Development & Commercialization, Inc. 20
Not applicableUnknownNCT03696693
What this trial is testing

Effect of Chronic Rhinosinusitis on Voice of Children

Who this might be right for
Voice Disorders in Children
Assiut University 100
Post-approval studies (Phase 4)UnknownNCT04863638
What this trial is testing

A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated

Who this might be right for
Covid19
China National Biotec Group Company Limited 4,400
Not applicableUnknownNCT06511635
What this trial is testing

Multicenter Quantitative and Qualitative Study of the Determinants of Participation in a Cytomegalovirus Preventive Vaccine Study in France in Women Aged 18 to 40 Years Old.

Who this might be right for
Recruitment
Centre Hospitalier Universitaire de Saint Etienne 306
Early research (Phase 1)UnknownNCT06167915
What this trial is testing

Safety and Immunogenicity of Recombinant COVID-19 Trivalent Protein Vaccine （CHO Cell）LYB002V14 in Booster Vaccination

Who this might be right for
SARS-CoV-2COVID-19 Vaccine
Guangzhou Patronus Biotech Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT05375838
What this trial is testing

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old

Who this might be right for
SARS-CoV-2Influenza
ModernaTX, Inc. 550
Post-approval studies (Phase 4)Study completedNCT01544478
What this trial is testing

V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110)

Who this might be right for
Cervical CancerCervical Intraepithelial NeoplasiaAdenocarcinoma in Situ
Merck Sharp & Dohme LLC 1,030
Early research (Phase 1)Active Not RecruitingNCT05831111
What this trial is testing

An Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants

Who this might be right for
Epstein-Barr Virus Infection
ModernaTX, Inc. 482
Large-scale testing (Phase 3)Study completedNCT04431453
What this trial is testing

Study of Remdesivir in Participants Below 18 Years Old With COVID-19

Who this might be right for
COVID-19
Gilead Sciences 59
Large-scale testing (Phase 3)Study completedNCT04649151
What this trial is testing

Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 4,328
Not applicableStudy completedNCT07587164
What this trial is testing

C-TST for Diagnosis of Latent Mycobacterium Tuberculosis Infection in Indonesia

Who this might be right for
Latent Tuberculosis Infection (LTBI)
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 300
Large-scale testing (Phase 3)Study completedNCT04918771
What this trial is testing

Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years Old

Who this might be right for
Acute Respiratory Viral Infection
Materia Medica Holding 435
Large-scale testing (Phase 3)Study completedNCT05037435
What this trial is testing

Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years.

Who this might be right for
Rotavirus InfectionsRotavirus Vaccines
Limited Liability Company Pharm Aid 40
Large-scale testing (Phase 3)Study completedNCT03199053
What this trial is testing

Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years Old

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 256
Testing effectiveness (Phase 2)Study completedNCT06324812
What this trial is testing

Evaluation of 611 in Chinese Children and Adolescents With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 128
Not applicableStudy completedNCT07462208
What this trial is testing

Oral Health Intervention in Hemodialysis Patients

Who this might be right for
Age ≥ 18 Years OldReceiving HD Treatment at Least 6 MonthsHaving no Hearing, Visual, or Speech Impairment+1 more
Çanakkale Onsekiz Mart University 82
Next Page